Neurocrine Biosciences | Vendas



Sales Alterar Data
AbbVie USD 13.34B 1.76B 2025-03
Acadia Pharmaceuticals USD 259.6M 9.2M 2024-12
Agios Pharmaceuticals USD 8.7M 2.03M 2025-03
ALKERMES USD 306.5M 123.5M 2025-03
Alnylam Pharmaceuticals USD 594.19M 1.02M 2025-03
Amgen USD 8.15B 936M 2025-03
Biogen USD 2.43B 24.7M 2025-03
BioMarin Pharmaceutical USD 745M 2.31M 2025-03
Cytokinetics USD 16.93M 16.46M 2024-12
Dynavax Technologies USD 72.03M 8.6M 2024-12
Exelixis USD 566.76M 27.21M 2024-12
Gilead Sciences USD 6.67B 899M 2025-03
Halozyme Therapeutics USD 298.01M 7.92M 2024-12
Incyte USD 1.05B 128.7M 2025-03
Ionis Pharmaceuticals USD 132M 94.58M 2025-03
Neurocrine Biosciences USD 627.7M 5.6M 2024-12
Pfizer USD 13.72B 4.04B 2025-03
Prothena USD 2.12M 1.15M 2024-12
Regeneron Pharmaceuticals USD 3.03B 760M 2025-03
Repligen USD 169M 1000K 2025-03
Sarepta Therapeutics USD 658.41M 191.24M 2024-12
Teva Pharmaceutical Industries USD 15.33B 11B 2024-12
Ultragenyx Pharmaceutical USD 164.88M 25.38M 2024-12
Vertex Pharmaceuticals USD 2.91B 140.1M 2024-12



Neurocrine Biosciences Vendas - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - May 2025.